Nanofibrous poly(vinyl alcohol)/chitosan contained carbonated hydroxyapatite nanoparticles scaffold for bone tissue engineering
Abstract
A scaffold that mimics the physicochemical structure of bone at the nanoscale level is an attractive alternative to conventional bone grafts, but its development remains a main challenge in bone tissue engineering today. This work describes the fabrication of a nanofibrous poly(vinyl alcohol)/chitosan/carbonated hydroxyapatite (PVA/CS/CHAp) scaffold. CHAp nanoparticles were synthesized using a co-precipitation method, and nanofibrous PVA/CS/CHAp scaffolds were fabricated by electrospinning using CHAp concentrations of 0, 5, 10, 15, and 20 wt%. The physicochemical properties of the scaffolds were evaluated by SEM, XRD, FTIR, and EDS, and the mechanical properties were determined by tensile strength tests. Swelling behavior, protein adsorption onto the scaffold surfaces, surface biomineralization, and cells viability were also evaluated in vitro. The addition of CHAp to the composite decreased the fiber diameter from ∼160 nm at 0 wt% to ∼139 nm at 15 wt% and great agglomerations were evident at 20 wt%. XRD, FTIR, and EDS showed effective incorporation of CHAp into the nanofibrous structure. This CHAp incorporation significantly increased the modulus of the scaffold at PVA/CS/CHAp 15 wt%, with an average 103.86 MPa, but tensile strength was not significantly altered. However, the elongation at break was decreased as the CHAp concentration increased. Swelling capacity of scaffold increases due to CHAp addition. Protein adsorption onto the scaffold increased 2.3fold at 20 wt%…
How strong is the evidence?
Evidence Hub reads this as a experimental / empirical study, done in animal and cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.